Astera Labs (NASDAQ:ALAB) Shares Down 2.4% on Insider Selling

Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) shares dropped 2.4% during mid-day trading on Thursday after an insider sold shares in the company. The stock traded as low as $211.28 and last traded at $211.60. Approximately 4,881,128 shares traded hands during mid-day trading, a decline of 5% from the average session volume of 5,135,559 shares. The stock had previously closed at $216.75.

Specifically, CEO Jitendra Mohan sold 96,089 shares of the business’s stock in a transaction dated Monday, November 16th. The shares were sold at an average price of $206.62, for a total value of $19,853,909.18. Following the completion of the sale, the chief executive officer owned 1,170,576 shares in the company, valued at approximately $241,864,413.12. The trade was a 7.59% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Sanjay Gajendra sold 96,089 shares of the company’s stock in a transaction on Monday, November 16th. The stock was sold at an average price of $206.62, for a total value of $19,853,909.18. Following the sale, the chief operating officer owned 1,022,949 shares of the company’s stock, valued at approximately $211,361,722.38. This represents a 8.59% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In related news, General Counsel Philip Mazzara sold 4,380 shares of the company’s stock in a transaction on Monday, November 16th. The stock was sold at an average price of $206.62, for a total transaction of $904,995.60. Following the completion of the sale, the general counsel directly owned 92,190 shares in the company, valued at $19,048,297.80. This represents a 4.54% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on ALAB shares. Morgan Stanley upped their price target on Astera Labs from $382.00 to $389.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 4th. BMO Capital Markets started coverage on Astera Labs in a research note on Thursday, November 5th. They set an “outperform” rating and a $375.00 target price on the stock. Zacks Research downgraded Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 5th. Royal Bank Of Canada reduced their target price on Astera Labs from $500.00 to $400.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 4th. Finally, UBS Group decreased their price target on Astera Labs from $300.00 to $290.00 and set a “neutral” rating for the company in a research note on Wednesday, November 4th. Thirteen analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $320.85.

View Our Latest Research Report on Astera Labs

More Astera Labs News

These are some of the ALAB news items that stood out recently:

  • Positive Sentiment: Fundamentals remain a support: Astera’s latest reported quarter beat earnings and revenue estimates, with revenue up 153.6% year over year. Article: Astera Labs’ expanding role in AI connectivity
  • Neutral Sentiment: The CEO, COO, general counsel and a vice president reported share sales. The filings say the transactions covered tax withholding on vested equity awards, and the executives retained substantial holdings, making them less indicative of discretionary selling.
  • Negative Sentiment: Recent coverage points to a shaky rebound and analyst price-target resets. The shares also sit below their 50- and 200-day moving averages, suggesting momentum remains weak even after strong earnings. Article: Record Q3 growth meets a shaky rebound

Astera Labs Trading Down 2.4%

The firm has a market cap of $36.98 billion, a price-to-earnings ratio of 84.30 and a beta of 3.85. The company has a fifty day moving average price of $288.88 and a 200-day moving average price of $257.84.

Astera Labs (NASDAQ:ALAB – Get Free Report) last released its quarterly earnings data on Tuesday, November 3rd. The company reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.19 by $0.13. Astera Labs had a net margin of 29.64% and a return on equity of 25.35%. The company had revenue of $584.90 million during the quarter, compared to analysts’ expectations of $550.78 million. During the same quarter in the previous year, the company earned $0.49 earnings per share. The firm’s revenue for the quarter was up 153.6% on a year-over-year basis. As a group, research analysts forecast that Astera Labs, Inc. will post 2.99 earnings per share for the current fiscal year.

Institutional Trading of Astera Labs

Several large investors have recently made changes to their positions in the company. Greenleaf Trust lifted its position in Astera Labs by 1.8% during the second quarter. Greenleaf Trust now owns 2,000 shares of the company’s stock worth $966,000 after purchasing an additional 36 shares during the period. Parkside Financial Bank & Trust lifted its holdings in shares of Astera Labs by 74.5% during the 2nd quarter. Parkside Financial Bank & Trust now owns 96 shares of the company’s stock worth $46,000 after acquiring an additional 41 shares during the period. Integrated Advisors Network LLC boosted its position in shares of Astera Labs by 4.8% during the 3rd quarter. Integrated Advisors Network LLC now owns 983 shares of the company’s stock worth $350,000 after acquiring an additional 45 shares in the last quarter. L2 Asset Management LLC boosted its position in shares of Astera Labs by 5.4% during the 3rd quarter. L2 Asset Management LLC now owns 910 shares of the company’s stock worth $324,000 after acquiring an additional 47 shares in the last quarter. Finally, Interchange Capital Partners LLC raised its position in Astera Labs by 4.4% during the third quarter. Interchange Capital Partners LLC now owns 1,187 shares of the company’s stock valued at $423,000 after purchasing an additional 50 shares in the last quarter. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

About Astera Labs

(Get Free Report)

Astera Labs, Inc. is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems. The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.

Read More

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.